Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors

American Journal of Roentgenology

Volumn 173, Issue 1, 1999, Pages 119-125

  Norfray, Joseph F ^a   Tomita, Tadanori ^b   Byrd, Sharon E ^b   Ross, Brian D ^c   Berger, Pierre A ^d   Miller, Rebecca S ^e  

^a Chicago Northside MRI Center   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^d MONSANTO COMPANY   (United States)

^e AMERICAN MEDICAL ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BENIGN TUMOR; BRAIN BIOPSY; BRAIN TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; NEUROCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION NECROSIS; SPECTROSCOPY;

EID: 0032965677     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.173.1.10397111     Document Type: Article

References (33)

1. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177:633-641
2. Bruhn H, Michaelis T, Merboldt KD, Hanicke W, Gyngell ML, Hamburger C. On the interpretation of proton NMR spectra from brain tumors in vivo and in vitro. NMR Biomed 1992;5:253-258
3. Demaerel P. In vivo localized single-voxel proton magnetic resonance spectroscopy of intracranial tumors. Int J Neuroradiol 1997;3:94-110
4. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992; 185:675-686
5. Kugel H, Heindel W, Ernestus RI, Bunke J, du Mesnil R, Friedman G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709
6. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-324
7. Negendank WG, Brown TR, Evelhoch JL, et al. Proceedings of a National Cancer Institute workshop: MR spectroscopy and tumor cell biology. Radiology 1992;185:875-883
8. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752
9. Rand SD, Prost R, Haughton V, et al. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from non neoplastic brain lesions. AJNR 1997;18:1695-1704
10. Ross B, Michaelis T. Clinical application of magnetic resonance spectroscopy. Magn Reson Q 1994; 10:191-247
11. Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR 1996;17:737-747
12. Sijens PE, Knopp MV, Brunetti A, et al. 1 H MR spectroscopy in patients with metastatic brain tumors: a multicentric study. Magn Reson Med 1995; 33:818-826
13. Tien RD, Lai PH, Smith JS, Lazeyra F. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR 1996; 167:201-209
14. Broniscer A, Gajjar A, Bhargava R, et al. Brain stem involvement in children with neurofibromatosis type I: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma. Neurosurgery 1997;40:331-337
15. Sutton LN, Wang Z, Gushard D, et al. Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 1992;31:195-202
16. 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro. J Neurosurg 1994;81:443-448
17. Sutton LN, Wang ZJ, Wehrli SL, et al. Proton spectroscopy of suprasellar tumors in pediatric patients. Neurosurgery 1997;41:388-394
18. Tzika AA, Vajapeyam S, Barnes PD. Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: preliminary observations. AJNR 1997;18:203-218
19. Wang Z, Sutton LN, Cnaan A, et al. Proton MR spectroscopy of pediatric cerebellar tumors. AJNR 1995;16:1821-1833
20. Wang Z, Zimmerman RA, Sauter R. Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR 1996;167:191-199
21. Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992;184:123-130
22. Jackson EF, Doyle TJ, Wolinsky JS, Narayana PA. Short TE hydrogen-1 spectroscope MR imaging of normal human brain: reproducibility studies. J Magn Reson Imaging 1994;4:545-551
23. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994;31:365-373
24. Kreis R, Farrow N, Ross BD. Localized 1-H NMR spectroscopy in patients with chronic hepatic encephalopathy analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991; 4:109-116
25. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 1992;5:226-233
26. DeStefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721-727
27. Kornberg H, Genuth S. Metabolism. In: The new encyclopaedia Britannica, vol. 23. Macropaedia. McHenry R, ed. Chicago: Encyclopaedia Britannica, 1993:893-928 N
28. Tozer GM, Griffiths JR. The contribution made by cell death and oxygenation to 31-P MRS observations of tumor energy metabolism. NMR Biomed 1992;5:279-289
29. Veech RL. The metabolism of lactate. NMR Biomed 1991;4:53-58
30. Berridge MJ. Inositol lipids and cell proliferation. Biochim Biophys Acta 1987;907:33-45
31. Ross BD. Biochemical considerations in 1H spectroscopy: glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed 1991;4:59-63
32. Moats RA, Watson L, Shonk T, et al. Added value of automated clinical proton MR spectroscopy of the brain. J Comput Assist Tomogr 1995;19:480-491
33. Shtem F. Clinical experimentation in magnetic resonance spectroscopy: a perspective from the National Cancer Institute. NMR Biomed 1992;5:325-328